TickerFacts.

Biolargo, Inc. (BLGO): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest EBITDA is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$4.48M
Year ended 2023-12-31
2010-12-31: -$4.19M2011-12-31: -$3.15M2012-12-31: -$4.71M2013-12-31: -$2.61M2014-12-31: -$3.38M2015-12-31: -$4.17M2016-12-31: -$4.92M2017-12-31: -$5.87M2018-12-31: -$6.36M2019-12-31: -$6.63M2020-12-31: -$7.53M2021-12-31: -$6.76M2022-12-31: -$5.34M2023-12-31: -$4.48M-$4.48M
2010-12-31 EBITDA (USD) 2023-12-31
Period endedEBITDAChange YoYSource filing
2023-12-31-$4.48Mn/m2025-03-31, From 2023-01-01
2022-12-31-$5.34Mn/m2024-04-01, From 2022-01-01
2021-12-31-$6.76Mn/c2023-03-31, From 2021-01-01
2020-12-31-$7.53Mn/m2022-03-31, From 2020-01-01
2019-12-31-$6.63Mn/m2021-03-30, From 2019-01-01
2018-12-31-$6.36Mn/m2020-03-31, From 2018-01-01
2017-12-31-$5.87Mn/m2019-03-29, From 2017-01-01
2016-12-31-$4.92Mn/m2018-03-16, From 2016-01-01
2015-12-31-$4.17Mn/m2017-03-30, From 2015-01-01
2014-12-31-$3.38Mn/m2016-03-30, From 2014-01-01
2013-12-31-$2.61Mn/m2015-03-31, From 2013-01-01
2012-12-31-$4.71Mn/m2014-04-01, From 2012-01-01
2011-12-31-$3.15Mn/m2013-03-29, From 2011-01-01
2010-12-31-$4.19Mn/a2012-04-06, From 2010-01-01